Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: A population-based study

Schaffner A, Risch L, Weber M, Thiel S, Jüngert K, Pichler M, Wohlwend N, Lung T, Ritzler M, Hillmann D, Copeland S, Renz H, Paprotny M, Risch M (2021)

Publication Type: Journal article

Publication year: 2021

Journal

Clinical Chemistry and Laboratory Medicine Walter de Gruyter

Book Volume: 59

Pages Range: E49-E51

Journal Issue: 2

DOI: 10.1515/cclm-2020-1347

Involved external institutions

Landesspital Liechtenstein

Liechtenstein (LI) Dr Risch

Switzerland (CH) Universitätsklinikum Gießen und Marburg (UKGM)

Germany (DE) Kantonsspital Graubünden

Switzerland (CH) Private Universität im Fürstentum Liechtenstein (UFL) / Private University in the Principality of Liechtenstein

Liechtenstein (LI)

How to cite

APA:

Schaffner, A., Risch, L., Weber, M., Thiel, S., Jüngert, K., Pichler, M.,... Risch, M. (2021). Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: A population-based study. Clinical Chemistry and Laboratory Medicine, 59(2), E49-E51. https://doi.org/10.1515/cclm-2020-1347

MLA:

Schaffner, Anna, et al. "Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: A population-based study." Clinical Chemistry and Laboratory Medicine 59.2 (2021): E49-E51.

BibTeX: Download